HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High Tumor Penetration of Paclitaxel Loaded pH Sensitive Cleavable Liposomes by Depletion of Tumor Collagen I in Breast Cancer.

Abstract
The network of collagen I in tumors could prevent the penetration of drugs loaded in nanoparticles, and this would lead to impaired antitumor efficacy. In this study, free losartan (an angiotensin inhibitor) was injected before treatment to reduce the level of collagen I, which could facilitate the penetration of nanoparticles. Then the pH-sensitive cleavable liposomes (Cl-Lip) were injected subsequently to exert the antitumor effect. The Cl-Lip was constituted by PEG(5K)-Hydrazone-PE and DSPE-PEG(2K)-R8. When the Cl-Lip reached to the tumor site by the enhanced permeability and retention (EPR) effect, PEG(5K)-Hydrazone-PE was hydrolyzed from the Cl-Lip under the low extra-cellular pH conditions of tumors, then the R8 peptide was exposed, and finally liposomes could be internalized into tumor cells by the mediation of R8 peptide. In vitro experiments showed both the cellular uptake of Cl-Lip by 4T1 cells and cytotoxicity of paclitaxel loaded Cl-Lip (PTX-Cl-Lip) were pH sensitive. In vivo experiments showed the Cl-Lip had a good tumor targeting ability. After depletion of collagen I, Cl-Lip could penetrate into the deep place of tumors, the tumor accumulation of Cl-Lip was further increased by 22.0%, and the oxygen distributed in tumor tissues was also enhanced. The antitumor study indicated free losartan in combination with PTX-Cl-Lip (59.8%) was more effective than injection with PTX-Cl-Lip only (37.8%) in 4T1 tumor bearing mice. All results suggested that depletion of collagen I by losartan dramatically increased the penetration of PTX-Cl-Lip and combination of free losartan and PTX-CL-Lip could lead to better antitumor efficacy of chemical drugs. Thus, the combination strategy might be a promising tactic for better treatment of solid tumors with a high level of collagen I.
AuthorsLi Zhang, Yang Wang, Yuting Yang, Yayuan Liu, Shaobo Ruan, Qianyu Zhang, Xiaowei Tai, Jiantao Chen, Tai Xia, Yue Qiu, Huile Gao, Qin He
JournalACS applied materials & interfaces (ACS Appl Mater Interfaces) Vol. 7 Issue 18 Pg. 9691-701 (May 13 2015) ISSN: 1944-8252 [Electronic] United States
PMID25845545 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Collagen Type I
  • Liposomes
  • Evans Blue
  • Losartan
  • Paclitaxel
Topics
  • Animals
  • Apoptosis (drug effects)
  • Breast Neoplasms (drug therapy, metabolism)
  • Cell Line, Tumor
  • Collagen Type I (metabolism)
  • Drug Delivery Systems
  • Endocytosis (drug effects)
  • Evans Blue
  • Female
  • Humans
  • Hydrogen-Ion Concentration
  • Liposomes
  • Losartan (pharmacology)
  • Mice, Inbred BALB C
  • Paclitaxel (pharmacology, therapeutic use)
  • Particle Size
  • Static Electricity
  • Tissue Distribution (drug effects)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: